Found: 6
Select item for more details and to access through your institution.
Microneedle-enhanced drug delivery: fabrication, characterization, and insights into release and permeation of nanocrystalline imiquimod.
- Published in:
- Frontiers in Drug Delivery, 2024, p. 1, doi. 10.3389/fddev.2024.1425144
- By:
- Publication type:
- Article
Tumor-infiltrating CCR2<sup>+</sup> inflammatory monocytes counteract specific immunotherapy.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1267866
- By:
- Publication type:
- Article
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1238861
- By:
- Publication type:
- Article
Complaint management of a quality defect in a nanoparticulate Imiquimod formulation in an investigator initiated academic phase I/II clinical trial Part 2.
- Published in:
- Pharmazeutische Industrie (Pharmind), 2023, v. 85, n. 3, p. 294
- By:
- Publication type:
- Article
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 514, doi. 10.3390/pharmaceutics15020514
- By:
- Publication type:
- Article
Complaint management of a quality defect in a nanoparticulate Imiquimod formulation in an investigator initiated academic phase I/II clinical trial.
- Published in:
- Pharmazeutische Industrie (Pharmind), 2023, v. 85, n. 2, p. 182
- By:
- Publication type:
- Article